Guidelines for the treatment of malaria
The purpose of this document is to provide comprehensible, global, evidence based guidelines to help formulate policies and protocols for the treatment of malaria. Information is presented on the treatment of: uncomplicated malaria, including disease in special groups (young children, pregnant women, people who are HIV-positive, travellers from non-malaria endemic regions) and in epidemics and complex emergency situations; and severe malaria. The guidelines do not deal with preventive uses of antimalarials, such as intermittent preventive treatment or chemoprophylaxis.
Related Content
- Enabling Delivery of Essential Health Services during the COVID 19 Outbreak: Guidance note
- Demonstrating the cost-effectiveness and sustainability of environmentally sound and locally appropriate alternatives to DDT for malaria vector control in Africa 2009–2017
- Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study
- Effectiveness of provider and community interventions to improve treatment of uncomplicated malaria in Nigeria: A cluster randomized controlled trial
- India State of the Environment Report : The Monthly Overview, September 2013
- World malaria report 2012